FILE PHOTO: A sign marks a Biogen facility in Massachusetts FILE PHOTO: A sign marks a Biogen facility in Cambridge, Massachusetts, U.S. January 26, 2017. REUTERS/Brian Snyder/File Photo/File Photo Post navigation Previous: Biogen to buy Reata for $6.5 billion to bulk up rare disease portfolio